1. Home
  2. KEQU vs HURA Comparison

KEQU vs HURA Comparison

Compare KEQU & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$39.28

Market Cap

106.6M

Sector

Industrials

ML Signal

HOLD

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$0.77

Market Cap

131.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
HURA
Founded
1906
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
131.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KEQU
HURA
Price
$39.28
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
6.4K
368.6K
Earning Date
12-10-2025
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.26
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$0.70
52 Week High
$71.33
$5.27

Technical Indicators

Market Signals
Indicator
KEQU
HURA
Relative Strength Index (RSI) 66.23 32.60
Support Level $37.19 $0.70
Resistance Level $38.50 $0.81
Average True Range (ATR) 1.15 0.06
MACD 0.30 0.05
Stochastic Oscillator 86.34 58.33

Price Performance

Historical Comparison
KEQU
HURA

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: